• Profile

5‐Fluorouracil 0.5%/salicylic acid 10% solution in the treatment of ano‐genital warts

Dermatologic Therapy Feb 12, 2022

Researchers sought to report on the efficacy of 5-fluorouracil 0.5%/salicylic acid 10% solution (5FU/SAsol) in the treatment of ano-genital warts (AGWs).

  • A total of 17 patients with AGWs (14 males, 3 females with a mean age of 34.2 years) consented to the off-label use of topical 5FU/Sasol.

  • Based on the AGWs number, researchers performed assessment of response to treatment: complete if there was complete clearance of the lesions; partial if there was > 50% reduction in the lesion number and none if there was < 50% reduction in the lesion number.

  • When partial and complete treatment responses were considered altogether, the 5FU/SAsol treatment appeared beneficial in 88% of the patients at 3 months and 94% at 6 months.

  • For 5-FU/SAsol, there was comparable clearance rate after 3 months of treatment to that of the other commonly used therapeutic modalities (liquid nitrogen cryotherapy, imiquimod 5% cream).

  • However, pain as an adverse event was recorded in several patients on imiquimod and almost all who underwent cryotherapy while a mild pain was rarely reported with 5-FU/Sasol.

  • The findings overall support considering 5-FU/SAsol not only in case of resistant/recurrent AGWs but also as the first therapeutic option, especially when the number of lesions is small.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen